Establishment of an Employee Benefit Trust
12 April 2023
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that it has established an Employee Benefit Trust called The MyHealthChecked PLC Benefit Trust (the “EBT”). The EBT will be for the benefit of current and future employees.
The EBT will act independently of the Company, managed by Ogier Global Trustee (Jersey) Limited, and is expected to make market purchases of ordinary shares of the Company ("Ordinary Shares") in order to, among other things, satisfy future option exercises of vested options granted pursuant to the Company's share option scheme.
The EBT will be funded by way of a loan from the Company and the Board believes that the formation of the EBT will help the Company in attracting new talent and incentivising existing members of the management team. The maximum amount of the loan to be made available to the EBT is currently capped at £50,000 but maybe varied in the future by agreement between the Company and the trustees of the EBT.
For further information contact:
|Penny McCormick, Chief Executive Officer||via Walbrook PR|
|SPARK Advisory Partners Limited (NOMAD)||Tel: +44 (0)20 3368 3550|
|Dowgate Capital Limited (Broker)||Tel: +44 (0)20 3903 7715|
|David Poutney / Nicholas Chambers|
|Walbrook PR Ltd (Media & IR)||Tel: +44 (0)20 7933 8780 or [email protected]|
|Paul McManus / Alice Woodings||Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654|
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, and the sample collection kits enable the collection of blood, urine nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.